Spectrum Pharmaceuticals Inc

Premium Company Profile

Publication Date	April 2008
Publisher	Datamonitor
Product Type	Report
Pages	46
ISBN Number	not applicable
Product Code	DAT11478

Price

£265.00
approximately: $521 | €337

PDF

PRINT £315 ($619 | €400)

Order above formats by FAX

Summary

Introduction

Spectrum Pharmaceuticals (Spectrum) is a biopharmaceutical company with a diversified portfolio of generic products and a pipeline of proprietary and collaborative products. Its therapeutic focus is on various cancer indications, infections and other diseases. The company product revenues are primarily from generic product sales.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Spectrum develops in-licensed drugs for the treatment and supportive care of cancer patients. The company also has a pipeline of pre-clinical neurological drug candidates for disorders such as attention-deficit hyperactivity disorder, schizophrenia, mild cognitive impairment and pain. The company's total revenues increased at a CAGR of 24% during 2002-2006 from $2 million to $6 million. The company derived revenues from product sales from 2004. Product sales from $0.2 million in 2004 to $0.1 million in 2006, primarily due to competitive market for generic products. Spectrum's total revenues between 2006 and 2010 are forecasted to grow at a CAGR of 16% from $6 million to $10 million. This represents an absolute growth of +$4 million solely contributed by the company's product ISO-Vorin [Levofolinic acid (LFA)] for cancer indications. Spectrum is expected to launch ISO-Vorin in 2008.

Reasons to Purchase

Access all the important information and analysis on the company in a single report Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company's adjusted five year financial data along with key ratios and market capitalization .

Content

Overview
Catalyst
Summary
- Company Structure
- Company Overview and Key Facts
- Business Description
- History
- Company Financials
- Stock Market Performance
- P&l
- Balance Sheet
- Cash Flow
- Products & Services
- Marketed Products
- Pipeline Products
- Historical Product Sales
- Ac Forecast Product Sales
- Competitors and Strategic Business Relationships
- Key Competitors
- Key Suppliers
- Key Clients
- Shareholding Structure
- Strategy
- Company View
- Corporate Strategy
- SWOT Analysis
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Value Chain Analysis
- Overview
- Product Development
- Scorecard
- Overview
- Scorecard Analysis
- Key Employees
- List of Key Employees
- Key Employee Biographies
- Financial and Operational Overview
- Financial and Operational Overview
Appendix
- Ask The Analyst
- Datamonitor Consulting
- Disclaimer
Table of Figures
- Figure 1: Spectrum Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Figure 2: Spectrum Pharmaceuticals - Key Strategic Products Revenues, 2006-2010 ($ Mn)
Table of Tables
- Table 1: Spectrum Pharmaceuticals - Key Facts
- Table 2: Spectrum Pharmaceuticals - Year-End Share Price and Market Capitalization, 2002-2006 ($)
- Table 3: Spectrum Pharmaceuticals - Key Events Impacting Share Price Performance
- Table 4: Spectrum Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 5: Spectrum Pharmaceuticals - Operating Cost Ratio Analysis, 2002-2006 (% of Total Revenues)
- Table 6: Spectrum Pharmaceuticals - Balance Sheet, 2002-2006 ($ Mn)
- Table 7: Spectrum Pharmaceuticals - Cash Flow, 2002-2006 ($ Mn)
- Table 8: Spectrum Pharmaceuticals - Marketed Products
- Table 9: Spectrum Pharmaceuticals - in-House Pipeline Products
- Table 10: Spectrum Pharmaceuticals - Collaboration Products
- Table 11: Spectrum Pharmaceuticals - Historical Product Sales, 2002-2006 ($ Mn)
- Table 12: Spectrum Pharmaceuticals - Forecast Sales, 2006-2010 ($ Mn)
- Table 13: Spectrum Pharmaceuticals - Key Competitors
- Table 14: Spectrum Pharmaceuticals - Key Suppliers
- Table 15: Spectrum Pharmaceuticals - Key Clients
- Table 16: Spectrum Pharmaceuticals - Key Shareholders
- Table 17: Spectrum Pharmaceuticals - SWOT Analysis Summary
- Table 18: Spectrum Pharmaceuticals - Value Chain Analysis
- Table 19: Spectrum Pharmaceuticals - Scorecard
- Table 20: Spectrum Pharmaceuticals - Key Employees
- Table 21: Spectrum Pharmaceuticals- Financial and Operational Overview